Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia |
Zhang, Qing
(Department of Radiology, Affiliated Hospital of Shandong Academy of Medical Sciences)
Wei, Yu-Mei (Department of Head and Neck Radiotherapy, Shandong Provincial Hospital Affiliated to Shandong University) Qi, Yuan-Gang (Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences) Li, Bao-Sheng (Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences) |
1 | Agulnik M, Epstein JB. Nasopharyngeal carcinoma: current management, future directions and dental implications. Oral Oncol 2008;44:617-627 DOI |
2 | Talmi YP, Horowitz Z, Bedrin L, Wolf M, Chaushu G, Kronenberg J, et al. Quality of life of nasopharyngeal carcinoma patients. Cancer 2002;94:1012-1017 DOI |
3 | Chambers MS, Garden AS, Kies MS, Martin JW. Radiationinduced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004;26:796-807 DOI |
4 | Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:751-760 DOI |
5 | van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiationinduced salivary dysfunction and xerostomia. Radiother Oncol 2009;93:545-552 DOI |
6 | Gregoire V, De Neve W, Eisbruch A, Lee N, Van den Weyngaert D, Van Gestel D. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist 2007;12:555-564 DOI |
7 | Leek H, Albertsson M. Pilocarpine treatment of xerostomia in head and neck patients. Micron 2002;33:153-155 DOI |
8 | Xu XQ, Choi YJ, Sung YS, Yoon RG, Jang SW, Park JE, et al. Intravoxel incoherent motion MR imaging in the head and neck: correlation with dynamic contrast-enhanced MR imaging and diffusion-weighted imaging. Korean Journal of Radiology 2016;17:641-649 DOI |
9 | Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220:621-630 DOI |
10 | Thoeny HC, De Keyzer F, Boesch C, Hermans R. Diffusionweighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004;20:786-790 DOI |
11 | Zhang Y, Ou D, Gu Y, He X, Peng W, Mao J, et al. Diffusionweighted MR imaging of salivary glands with gustatory stimulation: comparison before and after radiotherapy. Acta Radiol 2013;54:928-933 DOI |
12 | Dirix P, De Keyzer F, Vandecaveye V, Stroobants S, Hermans R, Nuyts S. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:1365-1371 DOI |
13 | Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3684-3690 DOI |
14 | Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346 DOI |
15 | Liu YJ, Lee YH, Chang HC, Huang TY, Chiu HC, Wang CW, et al. A potential risk of overestimating apparent diffusion coefficient in parotid glands. PLoS One 2015;10:e0124118 DOI |
16 | Sumi M, Takagi Y, Uetani M, Morikawa M, Hayashi K, Kabasawa H, et al. Diffusion-weighted echoplanar MR imaging of the salivary glands. AJR Am J Roentgenol 2002;178:959-965 DOI |
17 | Zhang L, Murata Y, Ishida R, Ohashi I, Yoshimura R, Shibuya H. Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy. J Magn Reson Imaging 2001;14:223-229 DOI |
18 | Chang HC, Juan CJ, Chiu HC, Cheng CC, Chiu SC, Liu YJ, et al. Effects of gender, age, and body mass index on fat contents and apparent diffusion coefficients in healthy parotid glands: an MRI evaluation. Eur Radiol 2014;24:2069-2076 DOI |
19 | Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505 DOI |
20 | Cho MA, Ko JY, Kim YK, Kho HS. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology. J Oral Rehabil 2010;37:185-193 DOI |
21 | Kato H, Kanematsu M, Toida M, Kawaguchi T, Shibata T, Kajita K, et al. Salivary gland function evaluated by diffusionweighted MR imaging with gustatory stimulation: preliminary results. J Magn Reson Imaging 2011;34:904-909 DOI |
22 | Studer G, Kirilova A, Jaffray D, Dawson L, Lockwood G, Bayley A, et al. Major salivary gland function: diffusion-weighted MRI (DWI) assessment before, during and after radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2005;63:S361 |
23 | Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70 DOI |